Development of Pharmaceutical Process Control Strategies for Drug Substance Manufacture

Chair(s):
Seibert, K., Eli Lilly and Company
Co-chair(s):
Marek, J. C., AbbVie, Inc.

This session encourages oral submission relevant to the methodologies and examples of selection and monitoring of critical quality attributes (CQA) to ensure desired performance in drug substance. Examples of the challenges and successes associated with the development and implementation of advanced control strategies, such as model predictive control and multiple input multiple output control, are discussed in these sessions. Examples of academic and industrial research involving the novel use of Process Analytical Tools for on-line monitoring of CQAs, applications of lab-based PAT to identify scalable process fingerprints, and advancements in technologies and methods toward real-time monitoring and release are also of interest in this session.

Papers:

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing


Individuals

AIChE Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00